Editas Medicine Inc header image

Editas Medicine Inc

EDIT

Equity

ISIN null / Valor 30992799

NASDAQ (2026-01-29)
USD 2.06%

Editas Medicine Inc
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Editas Medicine Inc is a gene editing company that specializes in developing genomic medicines for a range of diseases using CRISPR gene editing technology. The company's proprietary SLEEK gene editing approach enables high efficiency, multi-transgene knock-in of induced pluripotent stem cells, T cells, and natural killer cells, ensuring robust transgene expression. Editas Medicine works with CRISPR nucleases, including Cas9 and Cas12a, to revise, remove, and replace DNA in a highly targeted manner. The company sees CRISPR as a versatile platform technology with the potential to develop medicines for a wide variety of diseases by targeting DNA in any cell or tissue.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

53.7%1Y
-78.5%3Y
-96.6%5Y

Performance

125%1Y
94.0%3Y
89.5%5Y

Volatility

Market cap

201 M

Market cap (USD)

Daily traded volume (Shares)

1,325,347

Daily traded volume (Shares)

1 day high/low

1.265 / 1.175

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
4.00
Marc Bareth
Switzerland, 15 Apr 2025
star star star star star
Spekulative Anlage.

EQUITIES OF THE SAME SECTOR

TKH Group N.V.
TKH Group N.V. TKH Group N.V. Valor: 3074746
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%EUR 37.10
mVISE AG
mVISE AG mVISE AG Valor: 2377455
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.97%EUR 7.10
Tietoevry Oyj
Tietoevry Oyj Tietoevry Oyj Valor: 472478
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.14%EUR 18.04
Revenio Group Oyj
Revenio Group Oyj Revenio Group Oyj Valor: 1304192
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.49%EUR 20.30
SAP SE
SAP SE SAP SE Valor: 345952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-16.07%EUR 164.62
Rational AG
Rational AG Rational AG Valor: 635626
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%EUR 663.00
Verbio SE
Verbio SE Verbio SE Valor: 2731349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.84%EUR 24.52
SMA Solar Technology AG
SMA Solar Technology AG SMA Solar Technology AG Valor: 4337414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.85%EUR 36.50
freenet AG
freenet AG freenet AG Valor: 10575025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%EUR 30.18
Siltronic AG
Siltronic AG Siltronic AG Valor: 28423342
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.25%EUR 51.80